4733 related articles for article (PubMed ID: 9021355)
21. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
[TBL] [Abstract][Full Text] [Related]
22. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
Greene KE; Kettel LM; Yen SS
Fertil Steril; 1992 Aug; 58(2):338-43. PubMed ID: 1633899
[TBL] [Abstract][Full Text] [Related]
23. Relationship between gonadotrophin subunit gene expression, gonadotrophin-releasing hormone receptor content and pituitary and plasma gonadotrophin concentrations during the rebound release of FSH after treatment of ewes with bovine follicular fluid during the luteal phase of the cycle.
Brooks J; Crow WJ; McNeilly JR; McNeilly AS
J Mol Endocrinol; 1992 Apr; 8(2):109-18. PubMed ID: 1381179
[TBL] [Abstract][Full Text] [Related]
24. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
25. Antiovulatory actions of RU 486: the pituitary is not the primary site of action in vivo.
Heikinheimo O; Gordon K; Lähteenmäki P; Williams RF; Hodgen GD
J Clin Endocrinol Metab; 1995 Jun; 80(6):1859-68. PubMed ID: 7775633
[TBL] [Abstract][Full Text] [Related]
26. Luteinizing hormone response to gonadotrophin-releasing hormone in normal women undergoing ovulation induction with urinary or recombinant follicle stimulating hormone.
Messinis IE; Milingos S; Zikopoulos K; Hasiotis G; Seferiadis K; Lolis D
Hum Reprod; 1998 Sep; 13(9):2415-20. PubMed ID: 9806260
[TBL] [Abstract][Full Text] [Related]
27. Alteration of gonadotrophin and steroid hormone release, and of ovarian function by a GnRH antagonist in gilts.
Brüssow KP; Schneider F; Nürnberg G
Anim Reprod Sci; 2001 Apr; 66(1-2):117-28. PubMed ID: 11343847
[TBL] [Abstract][Full Text] [Related]
28. Anterior pituitary sensitivity in immature female rats stimulated with gonadotrophin releasing hormone in vivo: effect of priming with oestrogen, pregnant mare serum gonadotrophin or brain lesion.
De Ziegler D; Wilkinson M; Cassard D; Ruf KB
J Endocrinol; 1977 Jul; 74(1):99-109. PubMed ID: 327011
[TBL] [Abstract][Full Text] [Related]
29. Effect of gonadotropin-releasing hormone (GnRH) pulse frequency on serum and pituitary concentrations of luteinizing hormone and follicle-stimulating hormone, GnRH receptors, and messenger ribonucleic acid for gonadotropin subunits in cows.
Vizcarra JA; Wettemann RP; Braden TD; Turzillo AM; Nett TM
Endocrinology; 1997 Feb; 138(2):594-601. PubMed ID: 9002991
[TBL] [Abstract][Full Text] [Related]
30. Attenuation of gonadotrophin release and reserve in superovulated women by gonadotrophin surge attenuating factor (GnSAF).
Messinis IE; Templeton A
Clin Endocrinol (Oxf); 1991 Apr; 34(4):259-63. PubMed ID: 1908754
[TBL] [Abstract][Full Text] [Related]
31. Ovary mediates the effects of RU486 given during proestrus on the diestrous secretion of luteinizing hormone in the rat.
Tébar M; Ruíz A; Bellido C; Sánchez-Criado JE
Biol Reprod; 1996 Jun; 54(6):1266-70. PubMed ID: 8724354
[TBL] [Abstract][Full Text] [Related]
32. Pituitary and ovarian function in women receiving hormonal contraception.
Cohen BL; Katz M
Contraception; 1979 Nov; 20(5):475-87. PubMed ID: 393456
[TBL] [Abstract][Full Text] [Related]
33. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
Hemrika DJ; Slaats EH; Kennedy JC; de Vries Robles-Korsen TJ; Schoemaker J
J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046
[TBL] [Abstract][Full Text] [Related]
34. Hypothalamus-pituitary-ovarian axis in cyclic rats lacking progesterone actions.
Sánchez-Criado JE; Galiot F; Bellido C; Gonzalez D; Tébar M
Biol Reprod; 1993 Apr; 48(4):916-25. PubMed ID: 8485257
[TBL] [Abstract][Full Text] [Related]
35. Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.
Kekkonen R; Lähteenmäki P; Luukkainen T; Tuominen J
Fertil Steril; 1993 Oct; 60(4):610-5. PubMed ID: 8405512
[TBL] [Abstract][Full Text] [Related]
36. The effect of sex steroids on pituitary responsiveness to gonadotropin releasing hormone.
Eshkol A; Lunenfeld B; Insler V
J Steroid Biochem; 1975 Jun; 6(6):1061-6. PubMed ID: 1100906
[TBL] [Abstract][Full Text] [Related]
37. Induction of the gonadotrophin surge-inhibiting factor by FSH and its elimination: a sex difference in the efficacy of the priming effect of gonadotrophin-releasing hormone on the rat pituitary gland.
Koppenaal DW; van Dieten JA; Tijssen AM; de Koning J
J Endocrinol; 1993 Aug; 138(2):191-201. PubMed ID: 8228727
[TBL] [Abstract][Full Text] [Related]
38. Gonadotropin, estrogen and progesterone response to long term gonadotropin-releasing hormone infusion at various stages of the menstrual cycle.
Jewelewicz R; Dyrenfurth I; Ferin M; Bogumil J; Vande Wiele RL
J Clin Endocrinol Metab; 1977 Oct; 45(4):662-7. PubMed ID: 334788
[TBL] [Abstract][Full Text] [Related]
39. Effect of varying concentrations of follicle stimulating hormone on the production of gonadotrophin surge attenuating factor (GnSAF) in women.
Messinis IE; Lolis D; Papadopoulos L; Tsahalina T; Papanikolaou N; Seferiadis K; Templeton AA
Clin Endocrinol (Oxf); 1993 Jul; 39(1):45-50. PubMed ID: 8348707
[TBL] [Abstract][Full Text] [Related]
40. Activity of gonadotrophin surge-attenuating factor during the luteal phase in superovulated women.
Messinis IE; MacTavish A; Templeton AA
J Reprod Fertil; 1993 Jan; 97(1):271-5. PubMed ID: 8464020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
